Valuation: Ovation Science Inc.

Market Cap 6L 4L 4L 3L 3L 3.87Cr 6L 39.24L 15.21L 1.9Cr 15.25L 14.92L 6.54Cr P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 8L 6L 5L 4L 4L 5.28Cr 8L 53.59L 20.77L 2.59Cr 20.83L 20.38L 8.93Cr EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.54%
Yield 2024 *
-
Yield 2025 -
1 day-53.95%
3 months+65.09%
6 months+18.64%
Current year+18.64%
Current year 0.02
Extreme 0.0212
0.08
1 year 0.01
Extreme 0.0136
0.08
3 years 0
Extreme 0.0025
0.12
5 years 0
Extreme 0.0023
0.12
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 30/10/2023
Chief Executive Officer 77 04/10/2017
Director TitleAgeSince
Director/Board Member 77 04/10/2017
Director/Board Member 63 04/10/2017
Director/Board Member 86 02/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-53.95%-.--% - - 4L
+2.00%+0.34%+4.05%-9.17% 23TCr
+0.81%-1.77%+56.10% - 5.19TCr
-1.47%+8.36%+160.70% - 985.08Cr
+3.00%+7.19%+3.91%-58.23% 647.74Cr
-2.96%+17.41%-40.98%-32.52% 468.09Cr
+5.11%+21.84%-13.16%+22.34% 455.4Cr
+3.22%+14.40%-13.11%-12.94% 370.41Cr
-2.21%+4.17%-28.40%-47.59% 347.75Cr
+4.17%+4.01%-21.14%-49.97% 247.08Cr
Average -4.19%+7.82%+12.00%-26.87% 3.54TCr
Weighted average by Cap. +1.74%-0.36%+15.72%-11.24%

Financials

2024 2025
Net sales 1L 79.81T 69.74T 64.04T 59.72T 75.98L 1L 8L 3L 37.27L 3L 3L 1.28Cr 67.89T 47.86T 41.82T 38.4T 35.81T 45.56L 69.03T 5L 2L 22.35L 2L 2L 77L
Net income -5L -3L -3L -3L -2L -3.06Cr -5L -31.07L -12.04L -1.5Cr -12.08L -11.81L -5.17Cr -6L -4L -4L -4L -3L -4.24Cr -6L -42.99L -16.66L -2.08Cr -16.71L -16.35L -7.16Cr
Net Debt 3L 2L 2L 1L 1L 1.78Cr 3L 18.06L 7L 87.28L 7L 7L 3.01Cr 2L 1L 1L 1L 1L 1.41Cr 2L 14.35L 6L 69.38L 6L 5L 2.39Cr
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume